全文获取类型
收费全文 | 1054篇 |
免费 | 28篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 66篇 |
儿科学 | 32篇 |
妇产科学 | 49篇 |
基础医学 | 120篇 |
临床医学 | 57篇 |
内科学 | 228篇 |
皮肤病学 | 30篇 |
神经病学 | 151篇 |
特种医学 | 15篇 |
外科学 | 58篇 |
综合类 | 4篇 |
预防医学 | 55篇 |
眼科学 | 49篇 |
药学 | 123篇 |
肿瘤学 | 53篇 |
出版年
2023年 | 2篇 |
2022年 | 6篇 |
2021年 | 13篇 |
2020年 | 7篇 |
2019年 | 18篇 |
2018年 | 22篇 |
2017年 | 8篇 |
2016年 | 10篇 |
2015年 | 13篇 |
2014年 | 19篇 |
2013年 | 29篇 |
2012年 | 58篇 |
2011年 | 68篇 |
2010年 | 37篇 |
2009年 | 23篇 |
2008年 | 65篇 |
2007年 | 77篇 |
2006年 | 122篇 |
2005年 | 101篇 |
2004年 | 89篇 |
2003年 | 108篇 |
2002年 | 64篇 |
2001年 | 18篇 |
2000年 | 11篇 |
1999年 | 14篇 |
1998年 | 4篇 |
1997年 | 6篇 |
1995年 | 3篇 |
1994年 | 5篇 |
1993年 | 7篇 |
1992年 | 10篇 |
1989年 | 5篇 |
1988年 | 3篇 |
1987年 | 3篇 |
1986年 | 5篇 |
1985年 | 3篇 |
1983年 | 2篇 |
1982年 | 7篇 |
1981年 | 2篇 |
1979年 | 6篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1974年 | 2篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1969年 | 1篇 |
1965年 | 1篇 |
1964年 | 1篇 |
排序方式: 共有1090条查询结果,搜索用时 0 毫秒
21.
Janiszewska H Bak A Pilarska M Heise M Junkiert-Czarnecka A Kuliszkiewicz-Janus M Całbecka M Jaźwiec B Wołowiec D Kuliczkowski K Haus O 《Haematologica》2012,97(3):366-370
Germline mutations of the CHEK2 gene have been reported in some myeloid and lymphoid malignancies, but their impact on development of essential thrombocythemia has not been studied. In 16 out of 106 (15.1%) consecutive patients, newly diagnosed with essential thrombocythemia, we found one of four analyzed CHEK2 mutations: I157T, 1100delC, IVS2+1G>A or del5395. They were associated with the increased risk of disease (OR=3.8; P=0.002). The median age at ET diagnosis among CHEK2+/JAK2V617F+ patients was seven years lower than that among CHEK2-/JAK2V617F+ (52 vs. 59 years; P=0.04), whereas there was no difference in the medians of hematologic parameters between these groups. The results obtained suggest that CHEK2 mutations could potentially contribute to the susceptibility to essential thrombocythemia. The germline inactivation of CHEK2, as it seems, has no direct impact on the development of disease, but it could cause disruption of cell cycle checkpoints and initiate or support the cancerogenic process of essential thrombocythemia at a younger age. 相似文献
22.
Maija Vaittinen Dorota Kaminska Pirjo K?kel? Matti Eskelinen Marjukka Kolehmainen Jussi Pihlajam?ki Matti Uusitupa Leena Pulkkinen 《Diabetes》2013,62(11):3747-3750
We have previously demonstrated that the expression of calcineurin-like phosphoesterase domain containing 1 (CPPED1) decreases in adipose tissue (AT) after weight reduction. However, the function of CPPED1 in AT is unknown. Therefore, we investigated whether the change in CPPED1 expression is connected to changes in adipocyte glucose metabolism. First, we confirmed that the expression of CPPED1 decreased after weight loss in subcutaneous AT. Second, the expression of CPPED1 did not change during adipocyte differentiation. Third, CPPED1 knockdown with small interfering RNA increased expression of genes involved in glucose metabolism (adiponectin, adiponectin receptor 1, and GLUT4) and improved insulin-stimulated glucose uptake. To conclude, CPPED1 is a novel molecule involved in AT biology, and CPPED1 is involved in glucose uptake in adipocytes.Lifestyle modification improves glucose metabolism and results in a substantial reduction in the risk of type 2 diabetes in the long-term (1). In searching new putative genes related to obesity and type 2 diabetes, we have previously demonstrated a multitude of changes in adipose tissue (AT) gene expression in response to weight reduction in individuals with metabolic syndrome (2,3). Among the downregulated genes was calcineurin-like phosphoesterase domain containing 1 (CPPED1) (2); its function in AT is completely unknown.Therefore, we continued to study the role of CPPED1 in AT in more detail. Interestingly, the experiment using a Simpson-Golabi-Behmel syndrome (SGBS) cell strain demonstrated an impact of CPPED1 small interfering RNA (siRNA) on insulin-stimulated glucose uptake in mature adipocytes. Overall, the results demonstrate that CPPED1 is a novel molecule expressed in AT and is related to adipocyte function. 相似文献
23.
Ostrowska Dahlgren B Allen M Lindstr?m AC Bjerke M Blomstr?m-Lundqvist C 《Journal of interventional cardiac electrophysiology》2012,34(1):11-18
Aims
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by fibrofatty replacement of muscular fibers predominantly in the right ventricle and with ventricular arrhythmias as the main clinical manifestation. Mutations in several components of the desmosome genes have been identified and mutations of the plakophilin-2 (PKP-2) gene are a common cause of ARVC. The aim of this study is to investigate the correlation between genotype and phenotype in a family with a novel PKP-2 variant. 相似文献24.
Intracellular distribution of differentially phosphorylated dual‐specificity tyrosine phosphorylation‐regulated kinase 1A (DYRK1A) 下载免费PDF全文
Wojciech Kaczmarski Madhabi Barua Bozena Mazur‐Kolecka Janusz Frackowiak Wieslaw Dowjat Pankaj Mehta David Bolton Yu‐Wen Hwang Ausma Rabe Giorgio Albertini Jerzy Wegiel 《Journal of neuroscience research》2014,92(2):162-173
The gene encoding dual‐specificity tyrosine phosphorylation‐regulated kinase 1A (DYRK1A) is located within the Down syndrome (DS) critical region of chromosome 21. DYRK1A interacts with a plethora of substrates in the cytosol, cytoskeleton, and nucleus. Its overexpression is a contributing factor to the developmental alterations and age‐associated pathology observed in DS. We hypothesized that the intracellular distribution of DYRK1A and cell‐compartment‐specific functions are associated with DYRK1A posttranslational modifications. Fractionation showed that, in both human and mouse brain, almost 80% of DYRK1A was associated with the cytoskeleton, and the remaining DYRK1A was present in the cytosolic and nuclear fractions. Coimmunoprecipitation revealed that DYRK1A in the brain cytoskeleton fraction forms complexes with filamentous actin, neurofilaments, and tubulin. Two‐dimensional gel analysis of the fractions revealed DYRK1A with distinct isoelectric points: 5.5–6.5 in the nucleus, 7.2–8.2 in the cytoskeleton, and 8.7 in the cytosol. Phosphate‐affinity gel electrophoresis demonstrated several bands of DYRK1A with different mobility shifts for nuclear, cytoskeletal, and cytosolic DYRK1A, indicating modification by phosphorylation. Mass spectrometry analysis disclosed one phosphorylated site in the cytosolic DYRK1A and multiple phosphorylated residues in the cytoskeletal DYRK1A, including two not previously described. This study supports the hypothesis that intracellular distribution and compartment‐specific functions of DYRK1A may depend on its phosphorylation pattern. © 2013 Wiley Periodicals, Inc. 相似文献
25.
Bozena Debska Ewa Spychaj-Fabisiak Wiesaw Szulc Renata Gaj Magdalena Banach-Szott 《Materials》2021,14(12)
The major indicator of soil fertility and productivity are humic acids (HAs) arising from decomposition of organic matter. The structure and properties of HAs depend, among others climate factors, on soil and anthropogenic factors, i.e., methods of soil management. The purpose of the research undertaken in this paper is to study humic acids resulting from the decomposition of crop residues of wheat (Triticum aestivum L.) and plant material of thuja (Thuja plicata D.Don.ex. Lamb) using electron paramagnetic resonance (EPR) spectroscopy. In the present paper, we report EPR studies carried out on two types of HAs extracted from forest soil and incubated samples of plant material (mixture of wheat straw and roots), both without soil and mixed with soil. EPR signals obtained from these samples were subjected to numerical analysis, which showed that the EPR spectra of each sample could be deconvoluted into Lorentzian and Gaussian components. It can be shown that the origin of HAs has a significant impact on the parameters of their EPR spectra. The parameters of EPR spectra of humic acids depend strongly on their origin. The HA samples isolated from forest soils are characterized by higher spin concentration and lower peak-to-peak width of EPR spectra in comparison to those of HAs incubated from plant material. 相似文献
26.
Mazij M Sobkowicz B Kosiński M Kwinecki P Lenartowska L Piszko P Sawa W Kowal J Wrabec K 《Kardiologia polska》2004,60(4):359-62; discussion 363-4
We present two patients with aortic valve disease who developed acute infective endocarditis. In both patients the disease started with infection of the upper respiratory tract. The patients were treated with antibiotics due to pneumonia. The diagnosis of infective endocarditis was established 4 months and 9 weeks after the onset of infection. The first patient died whereas the second underwent successful aortic valve replacement. 相似文献
27.
Mari Aikio Harri Elamaa David Vicente Valerio Izzi Inderjeet Kaur Lotta Seppinen Helen E. Speedy Dorota Kaminska Sanna Kuusisto Raija Sormunen Ritva Heljasvaara Emma L. Jones Mikko Muilu Matti Jauhiainen Jussi Pihlajam?ki Markku J. Savolainen Carol C. Shoulders Taina Pihlajaniemi 《Proceedings of the National Academy of Sciences of the United States of America》2014,111(30):E3043-E3052
28.
Malgorzata Gawel MD PhD Elzbieta Szmidt‐Salkowska MD PhD Anna Lusakowska MD PhD Monika Nojszewska MD PhD Anna Sulek MSc PhD Wioletta Krysa MSc PhD Marta Rajkiewicz MSc PhD Andrzej Seroka TECH Anna M. Kaminska MD PhD 《Muscle & nerve》2014,49(2):277-283
Introduction: Standard electromyography (EMG) is useful in the diagnosis of myotonic dystrophy type 1 (DM1) and type 2 (DM2), but it does not differentiate between them. The aim of this study was to estimate the utility of the short exercise test (SET) and short exercise test with cooling (SETC) in differentiating between DM1 and DM2. Methods: SET and SETC were performed in 32 patients with DM1 (mean age 35.8 ± 12.7 years) and 28 patients with DM2 (mean age 44.5 ± 12.5 years). Results: We observed a significant decline in compound motor action potential (CMAP) amplitude in DM1 with both SET and SETC immediately after effort. In DM2, there was no marked change in CMAP amplitude with either SET or SETC. Conclusions: SET and SETC may serve as useful tools for clinical differentiation between DM1 and DM2, and they may be used as a guide for molecular testing. Muscle Nerve 49 : 277–283, 2014 相似文献
29.
30.